279 related articles for article (PubMed ID: 16822686)
21. [Prevalence and incidence of HIV and hepatitis B among blood donors and estimated residual risk of transmission of HIV and HBV virus by blood transfusion. A study at the Provincial General Referee Hospital Bukavu, Democratic Republic of the Congo].
Namululi BA; Guerrieri C; Dramaix MW
Rev Epidemiol Sante Publique; 2013 Apr; 61(2):139-44. PubMed ID: 23498094
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
23. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
Fasola FA; Kotila TR; Akinyemi JO
Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
[TBL] [Abstract][Full Text] [Related]
24. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
Busch MP; Glynn SA; Stramer SL; Strong DM; Caglioti S; Wright DJ; Pappalardo B; Kleinman SH;
Transfusion; 2005 Feb; 45(2):254-64. PubMed ID: 15660836
[TBL] [Abstract][Full Text] [Related]
25. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil.
Maresch C; Schluter PJ; Wilson AD; Sleigh A
Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323
[TBL] [Abstract][Full Text] [Related]
26. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003.
Soldan K; Davison K; Dow B
Euro Surveill; 2005 Feb; 10(2):17-9. PubMed ID: 15735312
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
28. Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010.
Kim MJ; Park Q; Min HK; Kim HO
BMC Infect Dis; 2012 Jul; 12():160. PubMed ID: 22817275
[TBL] [Abstract][Full Text] [Related]
29. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
[TBL] [Abstract][Full Text] [Related]
30. [Risk of infection transmission by blood components].
Kubanek B; Cardoso M; Glück D; Koerner K
Infusionsther Transfusionsmed; 1993 Apr; 20(1-2):54-9. PubMed ID: 8504243
[TBL] [Abstract][Full Text] [Related]
31. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.
Whyte GS; Savoia HF
Med J Aust; 1997 Jun; 166(11):584-6. PubMed ID: 9201178
[TBL] [Abstract][Full Text] [Related]
32. [Study by the Professional Organization of German Transfusion Physicians on epidemiology of HIV- and hepatitis infections in blood donors].
Glück D; Maurer C; Kubanek B
Beitr Infusionsther Transfusionsmed; 1997; 34():1-4. PubMed ID: 9417330
[TBL] [Abstract][Full Text] [Related]
33. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT).
Pillonel J; Laperche S;
Euro Surveill; 2005 Feb; 10(2):5-8. PubMed ID: 15735313
[TBL] [Abstract][Full Text] [Related]
34. Risk of infection in health care workers following occupational exposure to a noninfectious or unknown source.
Kuruuzum Z; Yapar N; Avkan-Oguz V; Aslan H; Ozbek OA; Cakir N; Yuce A
Am J Infect Control; 2008 Dec; 36(10):e27-31. PubMed ID: 19084160
[TBL] [Abstract][Full Text] [Related]
35. Occupational blood-borne diseases in surgery.
Fry DE
Am J Surg; 2005 Aug; 190(2):249-54. PubMed ID: 16023440
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiological data on infections among blood donors in Germany 2007].
Offergeld R; Ritter S; Quabeck L; Hamouda O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Nov; 53(11):1188-96. PubMed ID: 20976426
[TBL] [Abstract][Full Text] [Related]
37. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
39. Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003).
Velati C; Fomiatti L; Baruffi L; Romanò L; Zanetti A;
Euro Surveill; 2005 Feb; 10(2):12-4. PubMed ID: 15735315
[TBL] [Abstract][Full Text] [Related]
40. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.
Rouet F; Chaix ML; Inwoley A; Anaky MF; Fassinou P; Kpozehouen A; Rouzioux C; Blanche S; Msellati P;
Clin Infect Dis; 2008 Feb; 46(3):361-6. PubMed ID: 18171303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
